Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
12 07 2019
Historique:
received: 09 04 2019
accepted: 09 07 2019
entrez: 14 7 2019
pubmed: 14 7 2019
medline: 31 3 2020
Statut: epublish

Résumé

Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden. 1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality. During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35-1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40-2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis). Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus.

Sections du résumé

BACKGROUND
Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden.
METHODS
1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality.
RESULTS
During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35-1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40-2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis).
CONCLUSION
Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus.

Identifiants

pubmed: 31299990
doi: 10.1186/s12933-019-0895-0
pii: 10.1186/s12933-019-0895-0
pmc: PMC6626411
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90

Références

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E76-123
pubmed: 23281092
Vascul Pharmacol. 2018 Oct;109:17-26
pubmed: 29879463
Cardiovasc Diabetol. 2017 Jun 6;16(1):74
pubmed: 28587650
J Am Coll Cardiol. 2019 Apr 2;73(12):1371-1382
pubmed: 30922468
Cardiovasc Diabetol. 2018 Feb 05;17(1):24
pubmed: 29402270
Cell Metab. 2018 Sep 4;28(3):337-352
pubmed: 30184484
Stroke. 2006 Jan;37(1):87-92
pubmed: 16339465
Handb Clin Neurol. 2014;126:167-74
pubmed: 25410221
Radiology. 2003 Nov;229(2):340-6
pubmed: 14500855
Circ Res. 2016 May 27;118(11):1808-29
pubmed: 27230643
J Atheroscler Thromb. 2018 Oct 1;25(10):1053-1066
pubmed: 29445076
Circulation. 1997 Sep 2;96(5):1432-7
pubmed: 9315528
Eur Heart J. 2012 Jan;33(2):183-90
pubmed: 21666250
Circulation. 2003 Oct 7;108(14):1664-72
pubmed: 14530185
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460
Cardiol Clin. 2014 Aug;32(3):439-55
pubmed: 25091969
Stroke. 1992 Dec;23(12):1705-11
pubmed: 1448818
Clin Cardiol. 2017 May;40(5):287-291
pubmed: 28026025
Cardiovasc Diabetol. 2017 Jul 28;16(1):94
pubmed: 28750634
J Am Coll Cardiol. 2012 Oct 16;60(16):1489-99
pubmed: 22999719
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Circulation. 2005 May 3;111(17):2203-9
pubmed: 15851593
Drug Deliv. 2011 Jan;18(1):74-8
pubmed: 20854110
Atherosclerosis. 2015 Aug;241(2):533-8
pubmed: 26093886
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123
pubmed: 30559236
Circulation. 2019 Mar 12;139(11):1384-1395
pubmed: 30586757
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Lancet Diabetes Endocrinol. 2018 Jun;6(6):435-437
pubmed: 29030201
Thromb Res. 2019 May;177:130-135
pubmed: 30897531
Diabetes Care. 2015 Oct;38(10):1921-9
pubmed: 26180107
J Cardiovasc Ultrasound. 2016 Jun;24(2):91-5
pubmed: 27358696

Auteurs

Matthias Hoke (M)

Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria.

Martin Schillinger (M)

Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria.

Erich Minar (E)

Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria.

Georg Goliasch (G)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Christoph J Binder (CJ)

Department of Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Florian J Mayer (FJ)

Department of Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. florian.mayer@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH